Key result
AFib in women with HFpEF is linked to ~170% greater death and cardiac hospitalization risk.
Why the study?
HFpEF is prevalent in women and associated with AF, but sex associations in AF-related HFpEF are not well explored.
Does female sex combined with atrial fibrillation increase the risk of cardiovascular events in patients with HFpEF?
Cohort (n=556)
Does female sex combined with atrial fibrillation increase the risk of cardiovascular events in patients with HFpEF?
Effect estimate: HR 2.7 (95% CI 1.4-5.1)
Women with HFpEF and atrial fibrillation represent a distinct high-risk phenotype with significantly worse left ventricular geometry, diastolic function, and higher risk of adverse cardiovascular outcomes compared to men or women without AF.
Women with HFpEF and AF warrant heightened vigilance; this cohort study leaves open whether targeted interventions improve outcomes.
Background: Heart failure with preserved ejection fraction (HFpEF) is prevalent in women and is associated with atrial fibrillation (AF). However, sex associations in AF-related HFpEF are not well explored. Aim: We studied differences between men and women with and without AF-related HFpEF symptoms on left ventricular (LV) geometry and diastolic dysfunction (DD) and their effect on cardiovascular events. Methods: Retrospectively, HFpEF patients with and without a history of AF referred for echocardiography were studied. Echocardiographic assessments were focused on LV geometry and diastolic functions. Patients were followed for the occurrence of cardiac events defined as death and cardiac hospitalization. Results: We studied 556 patients [age: 66.7 ± 17 years, 320 (58%) women, 91 (16%) AF]. Compared to HFpEF without AF (HFpEF-AF), HFpEF with AF patients (HFpEF+AF) were older (76 ± 13.8 vs. 64.9 ± 17.3 years, p < 0.001), had more risk factors, comorbidities, left ventricular hypertrophy (32 vs. 13%, p < 0.001), higher relative wall thickness (0.50 ± 0.14 vs. 0.44 ± 0.15, p < 0.001), and DD (56 vs. 30%, all p < 0.001). HFpEF+AF women had the worst clinical, LV geometric, and diastolic functional profiles and highest rates of cardiovascular outcomes compared to HFpEF+AF men and were the only group to predict outcomes (HR: 2.7, 95%CI: 1.4−5.1), while HFpEF-AF women were a low-risk group; HFpEF+AF and HFpEF-AF men had intermediate cardiovascular outcomes which were confirmed after propensity score matching. Conclusions: Among patients with HFpEF, women with AF had more abnormal LV geometry and diastolic function and had an increased risk of adverse cardiovascular outcomes independent of traditional risk factors, comorbidities, and baseline diastolic function.
No takes yet. Share an insight, caveat, or question.
Omar et al. (2022) conducted a cohort in Heart failure with preserved ejection fraction (HFpEF) (n=556). Atrial fibrillation vs. No atrial fibrillation / Men was evaluated on Cardiac events defined as death and cardiac hospitalization (HR 2.7, 95% CI 1.4-5.1). Women with HFpEF and atrial fibrillation had the worst clinical profiles and a significantly increased risk of death and cardiac hospitalization (HR 2.7; 95% CI 1.4-5.1) compared to other groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: